dual gip/glp-1 receptor agonist Comparison between GLP-1 RA and the GLP-1/GIP Tirzepatide is a first-in-class dual

In the context of low or often undetectable neutralizing activity of antibodies, the fact that vaccine- or previous SARS-CoV-2-induced immunity can retain its ability to limit viral replication and to clear infection indicates the important protective roles of non-nAbs and T cells

Digestive issues, including nausea, vomiting, and abdominal discomfort, may arise

Vitamin B12 injections deliver this essential nutrient directly into the bloodstream to support energy levels, focus, and metabolic function

We included peer-reviewed randomized controlled trials, meta-analyses, and high-quality narrative or systematic reviews written in English that evaluated the effects of GLP-1 receptor agonists (liraglutide, semaglutide, or related analogues), as well as dual GIP/GLP-1 receptor agonists (such as tirzepatide), exercise training, or their combination on weight loss, body composition, metabolic, or cardiovascular outcomes in adults with obesity or type 2 diabetes

Singh I, Joseph P, Heerdt PM, Cullinan M, Lutchmansingh DD, Gulati M, et al